Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,306 recruiting studies in this area right now.
By phase
- Not applicable9,599
- Phase 24,428
- Phase 12,678
- Phase 1/Phase 21,650
- Phase 31,399
- Phase 2/Phase 3286
- Phase 4266
Top conditions
- Breast Cancer1,206
- Prostate Cancer645
- Cancer638
- Colorectal Cancer481
- Lung Cancer422
- Ovarian Cancer342
- Multiple Myeloma330
- Pancreatic Cancer288
- Gastric Cancer285
- Acute Myeloid Leukemia283
- Hepatocellular Carcinoma257
- Solid Tumor245
- Advanced Solid Tumor232
- Head and Neck Cancer228
- Cervical Cancer226
- Endometrial Cancer215
- Advanced Solid Tumors206
- Esophageal Cancer191
Leading sponsors
- M.D. Anderson Cancer Center454
- Fudan University305
- National Cancer Institute (NCI)294
- Memorial Sloan Kettering Cancer Center291
- Sun Yat-sen University274
- Mayo Clinic238
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences145
- City of Hope Medical Center145
- AstraZeneca133
- Ruijin Hospital128
Where studies are running
- California1,397
- Texas631
- Arizona508
- Florida436
- Alabama429
- New York406
- Massachusetts339
- Maryland331
- New Jersey275
- Pennsylvania236
Recruiting studies20,306 total
- NCT06856694Recruiting
Feedback tool to help men with prostate cancer decide on treatment
This trial tests a computer tool that analyzes your conversations with doctors. It aims to help you make a more informed choice about prostate cancer treatment.
Los Angeles, CaliforniaAges 18 years+ - NCT06846463RecruitingPhase 2
Zanubrutinib for DLBCL with specific genetic changes
This trial tests a targeted drug called zanubrutinib combined with standard chemotherapy (R-CHOP) for people with DLBCL who have specific genetic changes in their tumor. The goal is to see if adding this drug can improve outcomes.
Richmond, VirginiaAges 18 years+ - NCT06848868RecruitingPhase 1
Clinic-based scope for bladder cancer follow-up
This trial tests if a procedure done in the clinic, without general anesthesia, can safely check the upper urinary tract after kidney-sparing surgery for urothelial cancer. It may reduce the need for hospital visits.
Hong KongAges 18 years+ - NCT06857006Recruiting
Comparing radiation margins for brain tumors
This trial tests two different radiation margins (how much healthy tissue is included around a brain tumor) during a single treatment session. It aims to see which margin is better at controlling brain metastases while reducing side effects.
Birmingham, AlabamaAges 19 years+ - NCT06850090RecruitingPhase 3
Comparing two chemo drugs before radiation for rectal cancer
This trial tests if a newer chemo pill (TAS-102) works better than the standard pill (capecitabine) when given before radiation and surgery for rectal cancer. It is for people with stage II or III rectal cancer that has certain high-risk features.
Jinan, ShandongAges 18–75 - NCT06851429Recruiting
Ovarian cancer detection on CT scans using artificial intelligence
This trial tests a computer program (artificial intelligence) that looks at CT scans of the pelvis to help find ovarian cancer. If it works, it could help doctors diagnose this cancer earlier and more accurately.
Taoyuan City, Guishan DistrictAges 20 years+ - NCT06852313Recruiting
Saving the ovaries: surgery for simple cysts in kids
This study looks at surgery to remove simple ovarian cysts in children and teens while trying to save the ovary. It aims to find the best way to treat these cysts and keep the ovary working well.
BaselAges 1–18 - NCT06856499RecruitingPhase 1
Cirtuvivint and Olaparib for BRCA-related ovarian cancer
This trial tests a combination of two targeted drugs, cirtuvivint and olaparib, for a specific type of ovarian cancer that no longer responds to platinum chemotherapy. It may be an option if you have a BRCA mutation or HRD-positive tumor and have already tried a PARP inhibitor.
Aurora, ColoradoAges 18 years+ - NCT06855121Recruiting
Norwegian immunotherapy study for multiple myeloma patients
This study collects information from people with multiple myeloma, plasma cell leukemia, or AL-amyloidosis who are about to start a new type of immunotherapy. It helps doctors understand how these treatments work in real life.
ArendalAges 18 years+ - NCT06851052Enrolling by invitation
How do DNA changes happen in health and disease?
This study is looking at DNA changes (mutations) in healthy people and in people who may have DNA damage from things like the sun, smoking, past diseases, or treatments like radiation. The goal is to better understand how these changes happen and what they mean.
CambridgeAges 18 years+ - NCT06850402Recruiting
Testing a new microscope for cervical biopsies and LEEP
This study tests a new type of microscope that can take high-quality pictures of cervical tissue samples right in the clinic during a biopsy or LEEP procedure. It may help doctors see the tissue more clearly and quickly, without needing to send it to a lab.
Houston, TexasAges 25–49 - NCT06847269RecruitingPhase 2
CAR T cell therapy for children and young adults with CD19+ leukemia
This trial tests an immunotherapy called CAR T cells for leukemia that has come back or is hard to treat. It aims to use your own immune cells to fight the cancer.
Memphis, TennesseeAges Up to 21 years - NCT04053439Recruiting
Testing blood-clone risk to prevent chemotherapy complications
This study looks at a specific genetic/production change in blood-forming cells (“clonal hematopoiesis”) to understand who is more likely to have complications from lymphoma chemotherapy. It may help doctors predict risk and possibly reduce harmful side effects.
Toronto, OntarioAges 60 years+ - NCT05396612Recruiting
Studying the immune response in non-cancer-spread breast surgery
This study looks at how your immune system changes while you receive standard breast cancer treatment around the time of surgery. The goal is to learn why some people respond better than others, which could help future treatment choices.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06409936RecruitingPhase 2
Early use of asciminib for new CML patients
This trial tests the drug asciminib for people newly diagnosed with chronic myeloid leukemia (CML) who have been on treatment for less than a month. It aims to see if early treatment with asciminib is safe and effective.
BarcelonaAges 18 years+ - NCT06277219RecruitingPhase 1/Phase 2
Studying LAT010 for advanced solid tumors
This trial tests a new drug called LAT010 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective.
Margate, FloridaAges 18 years+ - NCT06149546Recruiting
Nutrition therapy for people having chemotherapy for pancreatic cancer
This trial tests whether a special nutrition program can help people with pancreatic cancer who are getting chemotherapy before surgery. The program includes diet changes, supplements, and exercise support to see if it improves strength, weight, and overall well-being.
Dublin, LeinsterAges 18 years+ - NCT06485947RecruitingPhase 1
Study testing dinutuximab beta with chemotherapy for neuroblastoma
This trial combines the immunotherapy drug dinutuximab beta with two different chemotherapy regimens to see if it works better for children with high-risk neuroblastoma that has spread. It may be an option for newly diagnosed patients who have not had cancer treatment before.
Utrecht, UtrechtAges 1.5 years–18 years - NCT06822452Recruiting
Outpatient vs. inpatient robotic prostate removal study
This study compares recovery experiences for men having robot-assisted prostate removal surgery as an outpatient (going home the same day) versus staying overnight in the hospital. It looks at early complications to see which approach might work better for eligible patients.
AvignonAges 18 years+ - NCT06689917Recruiting
JY231 injection for relapsed B-cell lymphoma or leukemia
This trial tests a new cell therapy called JY231 for people whose B-cell lymphoma or leukemia has come back or not responded to standard treatments. The therapy targets a protein on cancer cells called CD19 and may help your immune system fight the cancer.
Wuhan, HubeiAges 18–75 - NCT02885753RecruitingPhase 3
Liver-only metastatic colon cancer trial using targeted chemo
This Phase 3 trial tests different ways to deliver chemotherapy for colon cancer that has spread only to the liver (with limited possible tiny lung spots). It looks at whether the treatment plan improves outcomes compared with another chemotherapy approach, using oxaliplatin and LV5FU2 (with or without irinotecan) plus an added targeted medicine.
BrusselsAges 18 years+ - NCT04266977Recruiting
Low-dose steroid timing for newly diagnosed brain tumor surgery
This trial looks at using dexamethasone (a steroid medicine) in a more restricted way for people newly diagnosed with likely glioblastoma who are planned for brain surgery. The goal is to see whether limiting steroid use can still control symptoms while reducing steroid exposure.
Sankt Gallen, St.GallenAges 18–90 - NCT05029063RecruitingPhase 3
Rivaroxaban to prevent clots in cancer patients with new catheters
This Phase 3 study tests whether the medicine rivaroxaban can prevent dangerous blood clots in people with cancer who have a central venous catheter placed recently. It may help reduce clot risk while your catheter is in place, but you must meet safety and bleeding-risk criteria.
Halifax, Nova ScotiaAges 18 years+ - NCT05722795Recruiting
Imatinib to change triple-negative breast cancer to ER-positive
This trial studies whether imatinib (a pill medicine) can “convert” triple-negative breast cancer into an ER-positive type, which may change how the cancer behaves. If the conversion happens, it could open the door to more treatment options in the future.
GothenburgAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,306 recruiting oncology studies from the U.S. registry right now, out of 31,256 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.